Nitazenes, a class of synthetic drugs 40 times more potent than fentanyl, are steadily becoming more common on both sides of ...

Luzerne County Council must consider a request to spend $131,360 in opioid settlement funds on chiropractic services intended to prevent acute and chronic pain sufferers from turning to addictive ...

The three-judge panel further held that local governments are entitled to billions of dollars in abatement to help curb ...

A new opioid that has recently been detected in Toronto’s unregulated supply could increase the risk of overdose, says the ...

Since the height of the opioid epidemic, doctors have been prescribing fewer of these medications. A new study from UC San ...

The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for adults to treat moderate to severe acute pain. The drug, called Journavx (suzetrigine) ...

(The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. “Today’s ...